Problematic eating behaviours, changes in appetite, and weight gain in Major Depressive Disorder: The role of leptin

被引:24
|
作者
Mills, Jessica G. [1 ,2 ]
Thomas, Susan J. [1 ,2 ]
Larkin, Theresa A. [1 ,2 ]
Pai, Nagesh B. [1 ,2 ]
Deng, Chao [1 ,2 ,3 ]
机构
[1] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia
[2] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia
[3] Univ Wollongong, Antipsychot Res Lab, Wollongong, NSW, Australia
关键词
Leptin; Major Depressive Disorder; Appetite; Weight gain; Obesity; Food addiction; PLASMA LEPTIN; SERUM LEPTIN; PSYCHOMETRIC PROPERTIES; BLOOD-PRESSURE; CHRONIC STRESS; OBESITY; SYMPTOMS; ASSOCIATION; MOOD; OVERWEIGHT;
D O I
10.1016/j.jad.2018.07.069
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Appetite and weight changes are core symptoms of Major Depressive Disorder (MDD), and those with MDD are at increased risk of obesity, cardiovascular disease and metabolic disorders. Leptin promotes satiety, with leptin dysregulation and resistance noted in obesity. However, the role of leptin in weight changes in MDD is not established. This study investigates leptin levels in relation to appetite and weight changes and problematic eating behaviours in MDD. Methods: Plasma leptin levels, psychopathology and biometrics were compared between participants meeting DSM-5 diagnostic criteria for MDD (n = 63) and healthy controls (n = 60). Depressed participants were also sub-categorised according to increased, decreased or unchanged appetite and weight. The Dutch Eating Behaviour Questionnaire and Yale Food Addiction Scale were examined in a subset of participants with MDD. Results: Females with increased appetite/weight had higher leptin levels than those with stable or reduced appetite/weight, however males showed the opposite effect. Leptin levels were positively correlated with problematic eating behaviours. One quarter of the depressed subset, all females, met the Yale criteria for food addiction, approximately double the rates reported in general community samples. Limitations: The study is limited by a cross sectional design and a small sample size in the subset analysis of eating behaviours. Conclusions: The results provide new information about associations between leptin, sex-specific weight and appetite changes and problematic eating behaviours, which may be risk factors for cardiovascular and metabolic diseases in MDD, particularly in females. Future longitudinal research investigating leptin as a risk factor for weight gain in MDD is warranted, and may lead to early interventions aimed at preventing weight gain in at-risk individuals.
引用
收藏
页码:137 / 145
页数:9
相关论文
共 50 条
  • [31] The Complex Role of Oxytocin in Major Depressive Disorder
    Singh, Jasleen
    Carter, C. Sue
    Nazarloo, Hossein P.
    Hage, Brandon
    Halaris, Angelos
    CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, 2022, 12 (02): : 462 - 471
  • [32] Cariprazine's role in major depressive disorder
    Gasparinho, R.
    Fernandes, N.
    Ferreira, L.
    Santos, N.
    Costa, I.
    Alho, A.
    Martins, M.
    Costa, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S518 - S519
  • [33] Bupropion in the treatment of problematic online game play in patients with major depressive disorder
    Han, Doug Hyun
    Renshaw, Perry F.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (05) : 689 - 696
  • [34] Changes in Eating Behaviours Throughout Pregnancy: Associations with Gestational Weight Gain and Pre-pregnancy Body Mass Index
    Plante, Anne-Sophie
    Lemieux, Simone
    Drouin-Chartier, Jean-Philippe
    Weisnagel, S. John
    Robitaille, Julie
    Drapeau, Vicky
    Provencher, Veronique
    Morisset, Anne-Sophie
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2020, 42 (01) : 54 - 60
  • [35] The Absence of Items Addressing Increased Appetite or Weight in Depressive-Symptom Questionnaires: Implications for Understanding the Link between Major Depressive Disorder, Antidepressants, and Obesity
    Trevino-Alvarez, Andres M.
    Gluck, Marci E.
    McElroy, Susan L.
    Cuellar-Barboza, Alfredo B.
    BRAIN SCIENCES, 2024, 14 (08)
  • [36] Absence of weight gain during long-term treatment of major depressive disorder with gepirone-ER
    Roose, SP
    van Maanen, R
    Gibertini, M
    Ivgy-May, N
    Simmons, JH
    Baker, RA
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S183 - S183
  • [37] Maprotiline induced weight gain in depressive disorder: Changes in circulating ghrelin and adiponectin levels and insulin sensitivity
    Pinar, Murat
    Gulsun, Murat
    Tasci, Ilker
    Erdil, Ahmet
    Bolu, Erol
    Acikel, Cengizhan
    Doruk, Ali
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (01): : 135 - 139
  • [38] Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder
    Innes, Stuart
    Pariante, Carmine M.
    Borsini, Alessandra
    PSYCHONEUROENDOCRINOLOGY, 2019, 102 : 236 - 247
  • [39] Role of serum leptin in the regulation of weight gain in early infancy
    Harigaya, A
    Onigata, K
    Nako, Y
    Nagashima, K
    Morikawa, A
    BIOLOGY OF THE NEONATE, 1999, 75 (04): : 234 - 238
  • [40] Misdiagnosis of Primary Eating Disorder in an Individual With Major Depressive Disorder and Comorbid Catatonic Syndrome
    Howard, Adam
    Robbins-Welty, Gregg
    Schindler, Nicole J.
    Kincaid, Brian
    Komisar, Jonathan
    JOURNAL OF PSYCHIATRIC PRACTICE, 2024, 30 (06) : 447 - 448